Samsung Fire & Marine Insurance

Where we land

Samsung Fire & Marine's shares are priced as if its earnings will shrink over the next five years. Net profit has gone the other way, edging up to 2.1tn. We think the gloom built into the price is overdone, but only on one condition: the profit from the core insurance business has to steady. That condition matters because net income now exceeds operating income, which means recent earnings are being supported by something below the operating line rather than by the insurance business itself.

We award the company gold. The rest of this piece explains why the cheap price looks too pessimistic, and why the weak operating profit is the risk that could prove the price right.

What the business is

Samsung Fire & Marine is Korea's biggest non-life insurer. Non-life means it covers health, injury, property, cars and businesses rather than selling life policies. In our figures, commercial insurance makes up 82% of revenue. Personal insurance makes up the remaining 18%, and that is where most of the car cover sits.

Its operating margin, the share of revenue left after paying claims and the cost of running the company, is 8%. That is thin for an insurer of this size and standing, and it is the number much of what follows turns on.

Why now

The profit engine is multi-year health, injury and protection policies sold in Korea. These policies work differently from a one-year contract. Each one written adds to a stock of expected future profit, which is then released into earnings year after year. A healthy flow of new policies today therefore shows up in profits for a long time.

Two things have changed around the shares. They have rebounded sharply over the past six months and now sit near the top of the market for recent price performance. On the quality of the business, it remains among the strongest companies we rate. Against that, it has the thinnest operating margin of its peers: 8.4%, where comparable insurers earn between 11% and 24%.

We have held it in our Conviction 10 portfolio since August 2026, and it still qualifies. The question now is whether the rebound in the shares is running ahead of a core business that has weakened, or catching up with a valuation that had become too gloomy.

The case for

Analysts expect earnings per share to rise 16.2% next year. The direction of recent changes supports that view. Over the past 45 days, earnings forecasts were raised 10 times. They were cut only 6 times over the same period, so the weight of revisions has leaned upward.

The share price tells a similar story, though with an important qualification. The shares have climbed strongly over six months and now rank close to the top of the market on that measure. Over twelve months the position is only slightly better than it was, so this looks like a recovery from a dip rather than a fresh breakout. Investors who had marked the company down have been coming back.

The forecast needs careful reading, though. Operating profit fell over the past year, and net income is now above operating income. Unless the core insurance business recovers, a 16% rise in earnings would lean on support from below the operating line. The case for is therefore strongest if the analysts are right about a recovery in underwriting, not just about profits from elsewhere.

Where the growth could come from

The main driver is the long-term health and protection book. Our figures split revenue only into commercial and personal insurance; they do not size long-term policies on their own. From what the company is known to sell, they are most likely its largest business, and the pattern of its earnings fits that reading. Growth here depends on two things: how much new protection business is written at good margins, and whether medical claims stay under control. With sales growing at about 5% a year, that mix will decide whether the expected rise in earnings arrives. The evidence would be new long-term policy sales rising, the stock of expected future profit growing, and medical claims coming in at or below forecast.

The second channel is cash returned to shareholders. Korea has been pushing its listed companies to raise their value, and Samsung Fire has responded with higher dividends and by cancelling some of its own shares, backed by strong capital. This is not a revenue line, but it matters. A rising payout and a shrinking share count lift earnings and dividends per share faster than profit itself grows, and that can change how investors value the shares. The proof would be a higher share of profit paid out, or new cancellations, while the solvency ratio stays comfortably above the company's own target. The solvency ratio is the measure of how much capital an insurer holds against what it might have to pay out.

Car insurance is the swing factor. It sits mostly within personal insurance and carries thin margins, because premiums are regulated while repairs, parts and medical treatment after accidents keep getting more expensive. If premiums are held down while costs rise, the car book can tip into loss and drag on group profit. Oil adds a twist. Brent crude stood at $123 a barrel in late October, up 88% over a year, and dearer fuel can mean less driving and fewer accidents, though it is unclear how far that offsets rising costs. The signal to look for is a falling auto loss ratio, the share of car premiums paid back out in claims, without further cuts to premiums.

The fourth path is abroad. The company owns a stake in Canopius, an underwriter at Lloyd's of London, and is expanding its overseas reinsurance business, which means insuring other insurers. Both aim to reduce its reliance on a Korean market capped by an ageing population and near-saturated demand. The business is small next to the home operation, so for now it is an option rather than a driver. A rising share of premiums and profit from outside Korea, or a larger Canopius stake, would show it gaining weight.

The case against

The plainest problem is profitability. Every listed peer earns a higher operating margin. Zurich earns 11%, Tokio Marine 12%, and Chubb and Travelers each 22%. The shares trade at 13 times earnings, which is middle of the pack rather than cheap. MS&AD and Sompo trade at 9 times, and Travelers at 10 times, on much fatter margins.

The second problem is the direction of the core business. Operating profit fell by roughly a third in a year. In the twelve months to June 2025 it was 3.3tn. By the twelve months to June 2026 it was 2.0tn. Net profit still edged up over the same stretch, to 2.1tn. The gap tells us that recent earnings are being held up by something below the operating line, not by the insurance business, and support of that kind may not repeat.

The third problem is that the apparent bargain has an explanation. The shares trade at 0.8 times book value, which puts them among the cheapest in the market on that measure. Book value is roughly what the company's assets would be worth after paying all its debts and obligations. But return on equity, the profit earned on each unit of shareholders' money, is only 5.9%. A business that earns that little on its capital tends to trade below book, and its standing as a cheap stock has slipped over both six and twelve months.

Finally, growth is slowing. Sales rose 4.9% over the past year. That trails the 6.9% a year achieved over the past three years. The quality of the business still ranks near the top of the market, but it has drifted down a little over each of the past three, six and twelve months. None of these is fatal on its own. Together they describe a company that is solid but losing a little pace.

What the price assumes

Imagine the share price stays where it is for five years, and that by then the market values the company at 18.5 times earnings, the median for every profitable listed company we cover. For that to hold, earnings per share would have to shrink by about 7% a year. That is the gloom in the current price.

Because earnings are positive but not compounding steadily, comparing where they land is more telling than quoting a growth rate. The price implies earnings per share of about 35,711 in five years. If the recent trend in earnings per share simply continued, they would reach about 57,229. That trend amounts to growth of only about 3% a year, yet it still lands at 160% of what the price requires. Analysts' forecast for next year points the same way, upward.

None of that has gone unnoticed. The shares are up 49% over the past year and 43% over six months. Even after that run, the price still assumes earnings fall. The risk is that the market is right about the core business and wrong only in the timing.

The other side of the medal

The one risk to keep watching is that net profit is leaning on income from outside core insurance while operating profit has fallen from 3.3tn to 2.0tn. If that support fades, earnings follow, and the cheap price would turn out to have been a fair one.

This is the risk because it ties the company's other weaknesses together. Its operating margin of 8% is the thinnest in its peer group, so there is little buffer if claims rise. Net income exceeds operating income, which means the reported profit is not being earned where an insurer should earn it. Return on shareholders' equity is 6%, even though return on invested capital has a five-year median of 12%, a sign that the business has done better in the past than it is doing now.

The risk would be arriving if operating profit stayed stuck near its new lower level while the support below the operating line shrank. Net profit would then fall back toward what the insurance business alone can carry.

What to watch

The first signal is medical claims on the long-term health policies. If they come in at or below what the company has forecast, the profit already built into that book is being released as planned. That would point to operating profit climbing back from 2.0tn toward the 3.3tn of a year earlier, with the main business carrying earnings again. New long-term policy sales and growth in the stock of expected future profit would show the engine is still being fed.

The second signal is the car book's loss ratio, alongside any regulatory pressure on premiums. A falling ratio without further price cuts would remove a drag on group profit. The third is how the company returns cash: a higher payout or fresh share cancellations, with the solvency ratio comfortably above target, would show its capital being put to work for shareholders.

The warning sign is the opposite pattern. If operating profit stays near 2.0tn or falls further, and changes to earnings forecasts turn more cuts than raises, the expected rise in earnings would rest on non-operating support that may not repeat. In that case the stock's cheapness on book value would stop being an opportunity and become a value trap.

The numbers

Qualifications that apply to every figure above: net income exceeds operating income: earnings are supported by something below the operating line.

The same industry, for comparison

Research for information, not personal investment advice or a recommendation to buy, sell or hold any security: see Important information. Data as at 31 October 2026.